TC BioPharm Plc Price Patterns

Intrinsic Valuation Low Real High 0.01 0.01 0.01 Details

Naive Forecast Low Next High 0 0 0 Details

Bollinger Band Projection (param) Lower Middle Band Upper -0.1 0.01 0.01 Details

TC BioPharm After-Hype Price Density Analysis

TC BioPharm Estimiated After-Hype Price Volatility

TC BioPharm Pink Sheet Price Outlook Analysis

Notes

TC BioPharm Hype Timeline

TC BioPharm Plc is at this time traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. TCBPW is projected to increase in value after the next headline, with the price projected to jump to 0.00816 or above. The average volatility of media hype impact on the company the price is insignificant. The price increase on the next news is estimated to be 36.0%, whereas the daily expected return is at this time at 0.0%. The volatility of related hype on TC BioPharm is about 0.0%, with the expected price after the next announcement by competition of 0.01. TC BioPharm Plc has accumulated 1.8 M in total debt. TC BioPharm Plc has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist TC BioPharm until it has trouble settling it off, either with new capital or with free cash flow. So, TC BioPharm's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like TC BioPharm Plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for TCBPW to invest in growth at high rates of return. When we think about TC BioPharm's use of debt, we should always consider it together with cash and equity.Assuming the 90 days horizon the next projected press release will be within a week. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

TC BioPharm Related Hype Analysis

TC BioPharm Additional Predictive Modules

Most predictive techniques to examine TCBPW price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TCBPW using various technical indicators. When you analyze TCBPW charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of TC BioPharm stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as TC BioPharm Plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of TC BioPharm based on analysis of TC BioPharm hews, social hype, general headline patterns, and widely used predictive technical indicators.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

If you are still planning to invest in TC BioPharm Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TC BioPharm's history and understand the potential risks before investing.